Abstract:Abstract Background/Aims: Non-small cell lung cancer (NSCLC) is the leading global cause of cancer-related death. Due to the lack of reliable diagnostic or prognostic biomarkers, the prognosis of NSCLC remains poor. Consequently, there is an urgent need to explore the mechanisms underlying this condition in order to identify effective biomarkers. G protein signaling modulator 2 (GPSM2) is widely recognized as a determinant of mitotic spindle orientation. However, its role in cancer, especially NSCLC, remains uncertain. Methods: Tissue microarray (TMA) were used to compare differences in GPSM2 expression, and its relationship with clinical characteristics and prognosis. Wound healing assay, transwell assay and lung metastatic mice model were used to explore the biological function of GPSM2 on NSCLC cells in vitro and in vivo. Western blot and immunohistochemistry were conducted to investigate the potential pathways of GPSM2. Results: In this study, we found that GPSM2 was downregulated in NSCLC tissues and was correlated with a poor prognosis,and the expression status of GPSM2 was a favorable independent prognostic factor(HR = 0.222; 95% CI = 0.052 - 0.959; P = 0.044). Furthermore, the knockdown of GPSM2 promoted NSCLC cell metastasis in vitro and in vivo and accelerated the process of epithelial-to-mesenchymal transition (EMT). Mechanistically, we demonstrated that silencing GPSM2 induced cell metastasis and EMT via the ERK/GSK-3β/Snail pathway. Conclusion: These results confirm that GPSM2 plays an important role in NSCLC. Moreover, GPSM2, as an independent prognostic factor, may be a potential prognostic biomarker and drug target for NSCLC. Citation Format: Bofang Liu, Mingming Deng, Jingdong Zhang, Feifei Li, Weidong Han, Hongming Pan. Loss of GPSM2 promotes the metastasis of non-small cell lung cancer by inducing the expression of Snail [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 4709.

Knockdown of GSG2 inhibits the development and progression of non-small cell lung cancer in vitro and in vivo .

GSG2 Promotes Development and Predicts Poor Prognosis of Ovarian Cancer

Desmoglein-2 is Overexpressed in Non-Small Cell Lung Cancer Tissues and Its Knockdown Suppresses NSCLC Growth by Regulation of P27 and CDK2.

Effects and Mechanisms of GSG2 in Esophageal Cancer Progression.

Knockdown of GSG2 Inhibits Prostate Cancer Progressionin Vitroandin Vivo

Knockdown of G‐protein‐signaling modulator 2 promotes metastasis of non‐small‐cell lung cancer by inducing the expression of Snail

Comprehensive analysis of suppressor of cytokine signaling 2 protein in the malignant transformation of NSCLC

The Effects and Mechanisms of SLC34A2 in Tumorigenesis and Progression of Human Non-Small Cell Lung Cancer

SGO2 as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition in Lung Adenocarcinoma

Overexpression of TSPAN8 Promotes Tumor Cell Viability and Proliferation in Nonsmall Cell Lung Cancer.

Upregulation of SGOL2 Predicts Poor Prognosis and Facilitates Hepatocellular Carcinoma Progression via Dysregulating the Cell Cycle by Directly Activating MAD2

GINS2 Attenuates the Development of Lung Cancer by Inhibiting the STAT Signaling Pathway

Molecular Role of SGK3 Gene in Promoting the Progression of Non-small Cell Lung Cancer

Abstract 4709: Loss of GPSM2 Promotes the Metastasis of Non-Small Cell Lung Cancer by Inducing the Expression of Snail

SGPP2 is activated by SP1 and promotes lung adenocarcinoma progression

NCAPG2 Promotes Tumour Proliferation by Regulating G2/M Phase and Associates with Poor Prognosis in Lung Adenocarcinoma

GSK3β Overexpression Indicates Poor Prognosis and Its Inhibition Reduces Cell Proliferation and Survival of Non-Small Cell Lung Cancer Cells

SMC2 knockdown inhibits malignant progression of lung adenocarcinoma by upregulating BTG2 expression

Knockdown of GTF2E2 Inhibits the Growth and Progression of Lung Adenocarcinoma Via RPS4X in Vitro and in Vivo

SGK1 Protein Expression is a Prognostic Factor of Lung Adenocarcinoma That Regulates Cell Proliferation and Survival.

Nucleostemin Regulates Proliferation and Migration of Gastric Cancer and Correlates with Its Malignancy.